한글목차

세계의 말초동맥질환(PAD) 치료제 시장은 2030년까지 78억 달러에 도달

2023년에 48억 달러로 평가된 세계의 말초동맥질환(PAD) 치료제 시장은 분석 기간 2023년부터 2030년까지 CAGR 7.0%로 성장할 전망이며 2030년에는 78억 달러에 달할 것으로 예측된다. 이 보고서에서 분석한 부문 중 하나인 말초 스텐트는 CAGR 6.8%로 성장을 지속하고, 분석 기간 종료 시 18억 달러에 도달할 것으로 예측됩니다. 말초 혈관 성형술 풍선 부문의 성장률은 분석 기간 동안 CAGR 6.3%로 추정됩니다.

미국 시장은 13억 달러, 중국은 CAGR 6.6%로 성장 예측

미국의 말초동맥질환(PAD) 치료제 시장은 2023년 13억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 12억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023년부터 2030년까지 CAGR은 6.6%로 전망됩니다. 다른 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 6.2%와 5.8%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 5.4%로 성장할 것으로 예측됩니다.

세계의 말초 동맥 질환(PAD) 치료제 시장-주요 동향 및 촉진요인 요약

말초동맥질환(PAD)은 특히 당뇨병 환자와 흡연자를 포함한 40세 이상의 사람들에게 널리 나타나는 건강 문제로 미국에서도 약 720만 명이 앓고 있습니다. PAD는 운동 능력의 저하와 통증에 의해 생활의 질에 큰 영향을 미치고, 동맥경화성 질환과의 관련에 의해 사망 위험을 높입니다. 무증상에서부터 통증과 궤양을 특징으로 하는 심각한 허혈지까지, 그 증상은 다양합니다. 많은 경우에, 무증상이지만, 무증상 환자는 여전히 기능적 능력의 감소를 나타내며, 증상이 있는 환자와 유사한 허혈 위험에 직면하고 있으며, 증상 및 기초에 있는 동맥 경화성 위험 모두를 다루는 종합적 전략의 필요성을 강조합니다.

PAD에서의 치료의 진보는 심혈관 위험을 줄이고 중증 사례에서 점진적 증상과 조직 손실을 관리하는 다방면 접근법에 중점을 두었습니다. 그러나 PAD에 특화된 증거가 없기 때문에 다른 심혈관 질환으로부터의 외삽 데이터에 의존합니다. 일반적인 치료에는 스타틴, 항혈소판제, 안지오텐신 전환 효소 억제제 등이 있으며, 이는 주로 관상 동맥 또는 뇌 혈관 연구의 증거에 의해 뒷받침됩니다. 항혈소판 요법은 관상 동맥 질환 관리에서 확립되었지만, PAD에 특이적인 효능은 그다지 확실하지 않으며 치료 지침을 개선하기 위해 PAD에 특이적인 연구가 필요함을 보여줍니다. 한편, 무증상성 사례에 대해서는 아스피린이나 클로피도그렐과 같은 항혈소판요법이 그 유효성을 둘러싼 논의가 있음에도 불구하고 권장되고 있으며, 그 종합적인 유익성에 관한 조사가 현재 진행중 라는 것을 강조합니다.

PAD 치료제 시장의 중요한 성장 촉진요인으로는 조기 및 정확한 질병 검출을 강화하는 초음파 이중층 방법과 자기 공명 혈관 조영법과 같은 이미징 기술의 진보가 포함됩니다. 당뇨병이나 비만 등 생활습관병의 유병률 상승도 PAD 증례를 증가시켜 효과적인 치료에 대한 수요를 끌어올리고 있습니다. 교육 캠페인과 스크리닝 프로그램을 통한 일반 시민과 의료 관계자의 의식의 높아짐은 의약품 개발이나 맞춤형 의료에 있어서의 기술 혁신과 함께, 종래의 PAD 치료 어프로치의 한계를 밀어 가고 있습니다. 게다가 저침습 치료에 대한 동향, 원래 다른 심혈관계 질환을 위해 개발된 약제의 적응 확대, 진화하는 의료 정책과 상환 시나리오가 치료 패러다임을 재구성하고, PAD 관리에 있어서의 새로운 치료제의 채용을 촉진하고 있습니다.

조사 대상 기업 예(주목의 32사)

• AstraZeneca Plc.
• Bayer HealthCare Pharmaceuticals
• Bristol-Myers Squibb Company
• Merck & Co., Inc.
• Proteon Therapeutics, Inc.
• Sanofi SA
• Symic Bio, Inc.
• TheraVasc, Inc.

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향 및 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 기타 유럽
• 아시아태평양
• 세계 기타 지역

제4장 경쟁

영문목차

Global Peripheral Arterial Disease (PAD) Therapeutics Market to Reach US$7.8 Billion by 2030

The global market for Peripheral Arterial Disease (PAD) Therapeutics estimated at US$4.8 Billion in the year 2023, is expected to reach US$7.8 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Peripheral Stents, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.8 Billion by the end of the analysis period. Growth in the Peripheral Angioplasty Balloons segment is estimated at 6.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 6.6% CAGR

The Peripheral Arterial Disease (PAD) Therapeutics market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Peripheral Arterial Disease (PAD) Therapeutics Market - Key Trends and Drivers Summarized

Peripheral Artery Disease (PAD) is a widespread health issue, especially among individuals over 40 years old, including those with diabetes mellitus and smokers, with about 7.2 million affected in the U.S. alone. PAD significantly impacts quality of life through reduced mobility and pain, and increases mortality risk due to its connection with atherosclerotic disease. It varies in manifestation from asymptomatic cases to severe limb ischemia characterized by pain and ulcers. Despite often being symptom-free, asymptomatic patients still exhibit decreased functional capacity and face similar ischemic risks as those with symptoms, underlining the need for comprehensive strategies that tackle both symptoms and underlying atherosclerotic risks.

Treatment advancements in PAD have focused on multi-pronged approaches that reduce cardiovascular risks and manage claudication symptoms and tissue loss in critical cases. However, the lack of specific PAD-focused evidence has led to reliance on extrapolated data from other cardiovascular conditions. Common treatments include statins, antiplatelets, and angiotensin-converting enzyme inhibitors, largely supported by evidence from coronary or cerebrovascular studies. Although antiplatelet therapy is established in managing coronary diseases, its efficacy specifically for PAD is less certain, indicating a need for PAD-specific research to refine treatment guidelines. Meanwhile, for asymptomatic cases, antiplatelet therapies like aspirin and clopidogrel are recommended despite debates over their effectiveness, highlighting an ongoing investigation into their comprehensive benefits.

Significant growth drivers in the PAD therapeutics market include technological advancements in diagnostic imaging, like duplex ultrasound and magnetic resonance angiography, which enhance early and accurate disease detection. The rising prevalence of lifestyle diseases such as diabetes and obesity also escalates PAD cases, boosting demand for effective treatments. Increased public and medical awareness through educational campaigns and screening programs, along with innovations in drug development and personalized medicine, are pushing the boundaries of traditional PAD treatment approaches. Moreover, the trend towards minimally invasive procedures, expansion of drug indications originally developed for other cardiovascular conditions, and evolving healthcare policies and reimbursement scenarios are reshaping treatment paradigms, fostering greater adoption of novel therapeutics in the management of PAD.

Select Competitors (Total 32 Featured) -

• AstraZeneca Plc.
• Bayer HealthCare Pharmaceuticals
• Bristol-Myers Squibb Company
• Merck & Co., Inc.
• Proteon Therapeutics, Inc.
• Sanofi S.A.
• Symic Bio, Inc.
• TheraVasc, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Peripheral Arterial Disease (PAD) Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Global Economic Update
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of PAD Throws the Spotlight on Therapeutic Needs
  • Increasing Aging Population Expands Addressable Market Opportunity
  • Advancements in Drug Delivery Systems Drive Adoption of PAD Therapeutics
  • Innovations in Minimally Invasive Procedures Spur Market Growth
  • Development of Novel Antiplatelet Agents Generates Demand for Advanced Therapies
  • Increased Focus on Personalized Medicine Drives Adoption of Targeted Treatments
  • Technological Innovations in Imaging and Diagnostic Tools Expand Market Potential
  • Rising Healthcare Expenditure and Access to Treatment Propel Market Expansion
  • Emergence of Combination Therapies Generates New Opportunities for PAD Treatment
  • Patent Expirations and Generic Competition Affect Market Dynamics
  • Adoption of Digital Health Technologies Drives Market Adoption
  • Growing Importance of Vascular Health Awareness Campaigns Strengthens Market Demand
  • Innovations in Stem Cell and Gene Therapies Propel Growth in PAD Therapeutics
  • Expanding Applications of PAD Therapeutics in Other Vascular Diseases Drive Market Growth
  • Advancements in Biomarker Discovery and Diagnostics Sustain Market Growth
  • Integration with Telemedicine and Remote Monitoring Generates Market Opportunities
  • Technological Convergence with Other Therapeutic Modalities Expands Market Potential
  • Challenges in Clinical Trials and Regulatory Hurdles Impact the Market
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Peripheral Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 3: World 16-Year Perspective for Peripheral Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Peripheral Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Peripheral Angioplasty Balloons by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 6: World 16-Year Perspective for Peripheral Angioplasty Balloons by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Plaque Modification Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 9: World 16-Year Perspective for Plaque Modification Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Inferior Vena Cava (IVC) Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Inferior Vena Cava (IVC) Filters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 12: World 16-Year Perspective for Inferior Vena Cava (IVC) Filters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Hemodynamic Flow Alteration Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 15: World 16-Year Perspective for Hemodynamic Flow Alteration Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Peripheral Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Peripheral Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 18: World 16-Year Perspective for Peripheral Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Peripheral Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Peripheral Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 21: World 16-Year Perspective for Peripheral Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 22: World Peripheral Arterial Disease (PAD) Therapeutics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 26: USA Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 27: USA Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 28: USA 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 29: Canada Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 30: Canada Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 31: Canada 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
• JAPAN
  • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 32: Japan Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Japan Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 34: Japan 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
• CHINA
  • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 35: China Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 36: China Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 37: China 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
• EUROPE
  • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 38: Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 40: Europe 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
  • TABLE 41: Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • TABLE 42: Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 43: Europe 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
• FRANCE
  • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 44: France Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 45: France Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 46: France 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
• GERMANY
  • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 47: Germany Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 48: Germany Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 49: Germany 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 50: Italy Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Italy Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 52: Italy 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 53: UK Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 54: UK Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 55: UK 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Rest of Europe Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 58: Rest of Europe 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Peripheral Arterial Disease (PAD) Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Asia-Pacific Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 61: Asia-Pacific 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 62: Rest of World Recent Past, Current & Future Analysis for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • TABLE 63: Rest of World Historic Review for Peripheral Arterial Disease (PAD) Therapeutics by Type - Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • TABLE 64: Rest of World 16-Year Perspective for Peripheral Arterial Disease (PAD) Therapeutics by Type - Percentage Breakdown of Value Sales for Peripheral Stents, Peripheral Angioplasty Balloons, Plaque Modification Devices, Inferior Vena Cava (IVC) Filters, Hemodynamic Flow Alteration Devices, Peripheral Catheters and Peripheral Accessories for the Years 2014, 2024 & 2030

IV. COMPETITION